An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account.

by Xin Chen, Shizhong Xu, Michael McClelland, Farah Rahmatpanah, Anne Sawyers, Zhenyu Jia, Dan Mercola
Published 2012-01-01

Correction: Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse

by Zhenyu Jia, Farah B. Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola
Published 2012-01-01

Expression changes in the stroma of prostate cancer predict subsequent relapse.

by Zhenyu Jia, Farah B Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola
Published 2012-01-01

Correction: Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse.

by Zhenyu Jia, Farah B. Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola
Published 2012-01-01

Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.

by Zhenyu Jia, Michael B Lilly, James A Koziol, Xin Chen, Xiao-Qin Xia, Yipeng Wang, Douglas Skarecky, Manuel Sutton, Anne Sawyers, Herbert Ruckle, Philip M Carpenter, Jessica Wang-Rodriguez, Jun Jiang, Mingsen Deng, Cong Pan, Jian-Guo Zhu, Christine E McLaren, Michael J Gurley, Chung Lee, Michael McClelland, Thomas Ahlering, Michael W Kattan, Dan Mercola
Published 2014-01-01